September
2023
Closed pre-seed funding round
We are proud to be supported by three of the world’s leading venture capital
firms: LocalGlobe, Softbank Ventures Asia, and The Creator Fund.

October
2023
Moved Into Northdown House
We moved into our new offices in King’s Cross, built a state-of-the-art
biochemistry lab, and made the space our home.

November
2023
First team hires
We welcomed a group of world-class scientists and engineers to join our
team.

March
2024
Designed our first multiplexed biosensor, The Early A1 v0.1
We are able to test for up to eight different biomarkers on a single chip.

June
2024
Partnered with The Behavioural Insights Team (BIT)
The BIT helped us focus on developing a product that people truly want and
will use long-term.

August
2024
Partnered with the Barts Cancer Institute
We began translating a multi-cancer biomarker onto our technology.

September
2024
Team Expanded to 15
We hired incredibly talented colleagues with expertise in regulation, front-end
engineering, data science, and firmware.

December
2024
The Hardware Works
We completed and successfully tested our first fully functional end-to-end
prototype.
